Short chain fatty acids: Microbial metabolites for gut-brain axis signalling

[1]  P. M. Thompson,et al.  Autism-related dietary preferences mediate autism-gut microbiome associations , 2021, Cell.

[2]  A. Young,et al.  Perturbations in Gut Microbiota Composition in Psychiatric Disorders , 2021, JAMA psychiatry.

[3]  T. Dinan,et al.  Microbially-derived short-chain fatty acids impact astrocyte gene expression in a sex-specific manner , 2021, Brain, behavior, & immunity - health.

[4]  T. Dinan,et al.  Microbiota from young mice counteracts selective age-associated behavioral deficits , 2021, Nature Aging.

[5]  M. Dichgans,et al.  Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition , 2021, eLife.

[6]  T. Dinan,et al.  Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease , 2021, Neuroscience & Biobehavioral Reviews.

[7]  J. Wells,et al.  Microbial Regulation of Host Physiology by Short-chain Fatty Acids. , 2021, Trends in microbiology.

[8]  J. Cryan,et al.  Going with the grain: Fiber, cognition, and the microbiota-gut-brain-axis , 2021, Experimental biology and medicine.

[9]  Shancen Zhao,et al.  High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. , 2021, Cell metabolism.

[10]  J. Cryan,et al.  Gut peptides and the microbiome: focus on ghrelin , 2021, Current opinion in endocrinology, diabetes, and obesity.

[11]  N. Villarrubia,et al.  Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls , 2021, Cells.

[12]  N. Sudo,et al.  Corrigendum to “Dietary delivery of acetate to the colon using acylated starches as a carrier exerts anxiolytic effects in mice” , 2020, Physiology & Behavior.

[13]  Yan Shen,et al.  Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation , 2020, Brain, Behavior, and Immunity.

[14]  R. Glen,et al.  Regulation of blood – brain barrier integrity and cognition by the microbiome-1 associated methylamines trimethylamine-N-oxide and trimethylamine 2 3 , 2021 .

[15]  T. Dinan,et al.  Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human , 2020, EBioMedicine.

[16]  F. Ronchi,et al.  The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology , 2020, Frontiers in Immunology.

[17]  K. Kurokawa,et al.  Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder , 2020, mSystems.

[18]  K. Clément,et al.  Gut microbiota-derived metabolites as central regulators in metabolic disorders , 2020, Gut.

[19]  E. Fredericks,et al.  Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[20]  N. Alsharairi,et al.  The Role of Short-Chain Fatty Acids in the Interplay between a Very Low-Calorie Ketogenic Diet and the Infant Gut Microbiota and Its Therapeutic Implications for Reducing Asthma , 2020, International journal of molecular sciences.

[21]  P. Schulz,et al.  The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology. , 2020, Pharmacological research.

[22]  J. Álvarez-cermeño,et al.  Acetate correlates with disability and immune response in multiple sclerosis , 2020, PeerJ.

[23]  E. Gomaa.  Human gut microbiota/microbiome in health and diseases: a review , 2020, Antonie van Leeuwenhoek.

[24]  Kaoqi Lian,et al.  Long-lasting effects of postweaning sodium butyrate exposure on social behaviors in adult mice , 2020, Brain Research Bulletin.

[25]  Jing Xie,et al.  Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice , 2020, Translational Psychiatry.

[26]  G. Frisoni,et al.  Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.

[27]  T. Hausken,et al.  Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[28]  L. Atzori,et al.  Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease , 2020, mSystems.

[29]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[30]  Yuan Shi,et al.  Butyrate, but not Propionate, Reverses Maternal Diet-Induced Neurocognitive Deficits in Offspring. , 2020, Pharmacological research.

[31]  Tianyu Gong,et al.  Anti-neuroinflammatory Effect of Short-Chain Fatty Acid Acetate against Alzheimer's Disease via Upregulating GPR41 and Inhibiting ERK/JNK/NF-κB. , 2020, Journal of agricultural and food chemistry.

[32]  L. Friesen,et al.  Dietary Fiber Metabolites Regulate Innate Lymphoid Cell Responses , 2020, Mucosal Immunology.

[33]  B. Vervliet,et al.  Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial , 2020, Neuropsychopharmacology.

[34]  H. Yadav,et al.  Free Fatty Acid Receptors 2 and 3 as Microbial Metabolite Sensors to Shape Host Health: Pharmacophysiological View , 2020, Biomedicines.

[35]  R. Gold,et al.  Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease , 2020, Molecules.

[36]  Sonia González,et al.  An Overview on Fecal Branched Short-Chain Fatty Acids Along Human Life and as Related With Body Mass Index: Associated Dietary and Anthropometric Factors , 2020, Frontiers in Microbiology.

[37]  T. Dinan,et al.  Recipe for a Healthy Gut: Intake of Unpasteurised Milk Is Associated with Increased Lactobacillus Abundance in the Human Gut Microbiome , 2020, Nutrients.

[38]  A. Klegeris,et al.  Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells , 2020, Molecular and Cellular Neuroscience.

[39]  propionic acid , 2020, Catalysis from A to Z.

[40]  M. Sánchez-Niño,et al.  The Contribution of Histone Crotonylation to Tissue Health and Disease: Focus on Kidney Health , 2020, Frontiers in Pharmacology.

[41]  M. Scholz,et al.  Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism , 2020, Cell.

[42]  Cheng Yang,et al.  Potential effects of antibiotic‐induced gut microbiome alteration on blood–brain barrier permeability compromise in rhesus monkeys , 2020, Annals of the New York Academy of Sciences.

[43]  D. Liebler,et al.  Fatty Acid , 2020, Definitions.

[44]  E. Elinav,et al.  The microbiota programs DNA methylation to control intestinal homeostasis and inflammation , 2020, Nature Microbiology.

[45]  R. Frozza,et al.  The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.

[46]  J. Bogie,et al.  Fatty acid metabolism in the progression and resolution of CNS disorders. , 2020, Advanced drug delivery reviews.

[47]  Zachary D. Wallen,et al.  Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens , 2020, npj Parkinson's Disease.

[48]  T. Dinan,et al.  The gut microbiome in neurological disorders , 2019, The Lancet Neurology.

[49]  Zhenyi Tian,et al.  The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome , 2019, BMC Gastroenterology.

[50]  T. Dinan,et al.  Depression's Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome. , 2020, Annual review of psychology.

[51]  T. Dinan,et al.  Microbiota-Gut-Brain Axis: New Therapeutic Opportunities. , 2020, Annual review of pharmacology and toxicology.

[52]  Zongxin Ling,et al.  Effect of Clostridium Butyricum Against Microglia-Mediated Neuroinflammation in Alzheimer's Disease Via Regulating gut Microbiota and Metabolites Butyrate. , 2019, Molecular nutrition & food research.

[53]  A. Keshavarzian,et al.  Diet in Parkinson's Disease: Critical Role for the Microbiome , 2019, Front. Neurol..

[54]  A. Amedei,et al.  Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease , 2019, Front. Immunol..

[55]  I. Kimura,et al.  Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3 , 2019, Scientific Reports.

[56]  Shaojia Lu,et al.  Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration , 2019, Front. Psychiatry.

[57]  Alexander V. Zhdanov,et al.  Short‐chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  Yao Yao,et al.  Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis , 2019, Nutrients.

[59]  Kieran Rea,et al.  The Microbiota-Gut-Brain Axis. , 2019, Physiological reviews.

[60]  G. Fantuzzi,et al.  The association of short-chain fatty acids and leptin metabolism: a systematic review. , 2019, Nutrition research.

[61]  S. Miyake,et al.  Butyrate suppresses demyelination and enhances remyelination , 2019, Journal of Neuroinflammation.

[62]  C. Knauf,et al.  Targeting the Enteric Nervous System to Treat Metabolic Disorders? “Enterosynes” as Therapeutic Gut Factors , 2019, Neuroendocrinology.

[63]  N. Bray.  The microbiota–gut–brain axis , 2019 .

[64]  H. Rong,et al.  Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients. , 2019, Journal of psychiatric research.

[65]  B. Vervliet,et al.  The role of short-chain fatty acids in microbiota–gut–brain communication , 2019, Nature Reviews Gastroenterology & Hepatology.

[66]  Ming D. Li,et al.  Gut Microbiota Changes in Patients with Bipolar Depression , 2019, Advanced science.

[67]  Young-Mo Kim,et al.  Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice , 2019, Cell.

[68]  J. Raes,et al.  Tracking humans and microbes , 2019, Nature.

[69]  P. Xie,et al.  Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques , 2019, Neuropsychiatric disease and treatment.

[70]  A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma Patients , 2019, Case Medical Research.

[71]  L. Falomir-Lockhart,et al.  Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors , 2019, Front. Cell. Neurosci..

[72]  S. Celniker,et al.  Drosophila Histone Demethylase KDM5 Regulates Social Behavior through Immune Control and Gut Microbiota Maintenance. , 2019, Cell host & microbe.

[73]  K. Faber,et al.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..

[74]  S. Amor,et al.  Neuroimmunology – the past, present and future , 2019, Clinical and experimental immunology.

[75]  J. Hellman,et al.  Elevated Gut Microbiome-Derived Propionate Levels Are Associated With Reduced Sterile Lung Inflammation and Bacterial Immunity in Mice , 2019, Front. Microbiol..

[76]  J. Raes,et al.  The neuroactive potential of the human gut microbiota in quality of life and depression , 2019, Nature Microbiology.

[77]  L. Duan,et al.  Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome , 2019, Medicine.

[78]  L. T. Te Morenga,et al.  Carbohydrate quality and human health: a series of systematic reviews and meta-analyses , 2019, The Lancet.

[79]  Pingchang Yang,et al.  Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder , 2019, Scientific Reports.

[80]  Patrice D Cani,et al.  Microbial regulation of organismal energy homeostasis , 2019, Nature Metabolism.

[81]  T. Schmidt,et al.  Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers , 2018, mBio.

[82]  G. Frost,et al.  Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2 , 2018, Diabetes, obesity & metabolism.

[83]  Karl Kashofer,et al.  A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode , 2018, Bipolar disorders.

[84]  J. Pełka-Wysiecka,et al.  Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women , 2018, Nutrients.

[85]  Hyung-Kyoon Choi,et al.  Metabolomics and Lipidomics Approaches in the Science of Probiotics: A Review. , 2018, Journal of medicinal food.

[86]  Paul Theodor Pyl,et al.  Recovery of gut microbiota of healthy adults following antibiotic exposure , 2018, Nature Microbiology.

[87]  J. Shimizu,et al.  Propionate-producing bacteria in the intestine may associate with skewed responses of IL10-producing regulatory T cells in patients with relapsing polychondritis , 2018, PloS one.

[88]  M. Bellini,et al.  Fecal Clostridiales distribution and short‐chain fatty acids reflect bowel habits in irritable bowel syndrome , 2018, Environmental microbiology.

[89]  T. Dinan,et al.  Short‐chain fatty acids: microbial metabolites that alleviate stress‐induced brain–gut axis alterations , 2018, The Journal of physiology.

[90]  D. Kitzman,et al.  Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome , 2018, Scientific Reports.

[91]  M. V. van Zelm,et al.  Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders , 2018, Alimentary pharmacology & therapeutics.

[92]  T. Yada,et al.  Short-chain fatty acids suppress food intake by activating vagal afferent neurons. , 2018, The Journal of nutritional biochemistry.

[93]  F. Reimann,et al.  Free Fatty Acid Receptors in Enteroendocrine Cells. , 2018, Endocrinology.

[94]  Harry Sokol,et al.  Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. , 2018, Cell host & microbe.

[95]  Baodong Zheng,et al.  Short-chain fatty acids in control of energy metabolism , 2018, Critical reviews in food science and nutrition.

[96]  Á. Somogyi,et al.  Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids , 2018, PloS one.

[97]  Chun Cui,et al.  Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway , 2018, Brain, Behavior, and Immunity.

[98]  M. Schwab,et al.  Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy , 2018, Clinical and translational science.

[99]  Thomas Lengauer,et al.  Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development , 2018, Genome Medicine.

[100]  R. Glen,et al.  Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier , 2018, Microbiome.

[101]  Chenhong Zhang,et al.  Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes , 2018, Science.

[102]  F. Naclerio,et al.  Effect of a Protein Supplement on the Gut Microbiota of Endurance Athletes: A Randomized, Controlled, Double-Blind Pilot Study , 2018, Nutrients.

[103]  Chao Huang,et al.  Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition , 2018, Neurobiology of Disease.

[104]  Yunho Jin,et al.  Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model , 2018, PloS one.

[105]  S. Yamawaki,et al.  Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice , 2018, Brain Research.

[106]  Wei Zhao,et al.  Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine , 2018, Neuropharmacology.

[107]  S. Shibata,et al.  Gut Microbiota-Derived Short Chain Fatty Acids Induce Circadian Clock Entrainment in Mouse Peripheral Tissue , 2018, Scientific Reports.

[108]  G. Pasinetti,et al.  Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms , 2018, Expert review of neurotherapeutics.

[109]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[110]  K. Varady,et al.  The Association of Short-Chain Fatty Acids and Leptin Metabolism: A Systematic Review BY FERNANDA CARRAMASCHI GABRIEL , 2018 .

[111]  Defa Li,et al.  Butyrate: A Double-Edged Sword for Health? , 2018, Advances in nutrition.

[112]  M. Veldhoen,et al.  Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases , 2018, Nature Communications.

[113]  J. Doré,et al.  SCFAs strongly stimulate PYY production in human enteroendocrine cells , 2018, Scientific Reports.

[114]  F. Stumpff.  A look at the smelly side of physiology: transport of short chain fatty acids , 2018, Pflügers Archiv - European Journal of Physiology.

[115]  M. Giera,et al.  Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit , 2017, Gut.

[116]  Suzhi Liu,et al.  Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1 , 2017, Journal of the Neurological Sciences.

[117]  T. van de Wiele,et al.  Chronic Psychosocial Stress and Gut Health in Children: Associations With Calprotectin and Fecal Short-Chain Fatty Acids , 2017, Psychosomatic medicine.

[118]  L. Wood,et al.  Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis. , 2017, The American journal of clinical nutrition.

[119]  E. Hsiao,et al.  The Microbiome and Host Behavior. , 2017, Annual review of neuroscience.

[120]  R. Glen,et al.  Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier , 2017, bioRxiv.

[121]  Cemil Kerimoglu,et al.  Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage , 2017, Human molecular genetics.

[122]  T. A. Rosenberger,et al.  Increasing acetyl‐CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis , 2017, Journal of neurochemistry.

[123]  P. Luethy,et al.  Microbiota-Derived Short-Chain Fatty Acids Modulate Expression of Campylobacter jejuni Determinants Required for Commensalism and Virulence , 2017, mBio.

[124]  T. Dinan,et al.  Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite. , 2017, The Journal of nutrition.

[125]  W. Liao,et al.  Influence of diet on the gut microbiome and implications for human health , 2017, Journal of Translational Medicine.

[126]  Shervin Assari,et al.  The gut microbiome composition associates with bipolar disorder and illness severity. , 2017, Journal of psychiatric research.

[127]  G. Farrugia,et al.  Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production. , 2017, American journal of physiology. Gastrointestinal and liver physiology.

[128]  J. Pluznick.  Microbial Short-Chain Fatty Acids and Blood Pressure Regulation , 2017, Current Hypertension Reports.

[129]  N. Spencer,et al.  Regional differences in nutrient‐induced secretion of gut serotonin , 2017, Physiological reports.

[130]  A. Chiba,et al.  The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models , 2017, PloS one.

[131]  T. Dinan,et al.  Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice , 2017, Biological Psychiatry.

[132]  E. Hsiao,et al.  Interactions between the microbiota, immune and nervous systems in health and disease , 2017, Nature Neuroscience.

[133]  J. Delcour,et al.  Systemic availability and metabolism of colonic‐derived short‐chain fatty acids in healthy subjects: a stable isotope study , 2017, The Journal of physiology.

[134]  M. Surette,et al.  Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress , 2017, BMC Medicine.

[135]  Marco Prinz,et al.  Communicating systems in the body: how microbiota and microglia cooperate , 2017, Immunology.

[136]  T. Wolever,et al.  Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans , 2016, European Journal of Clinical Nutrition.

[137]  J. Sheridan,et al.  Stress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression. , 2016, Current topics in behavioral neurosciences.

[138]  J. Kaunitz,et al.  FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats , 2016, Digestive Diseases and Sciences.

[139]  G. Milligan,et al.  Free Fatty Acid Receptors , 2017 .

[140]  Hua Zhu,et al.  Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[141]  H. Flint,et al.  Formation of propionate and butyrate by the human colonic microbiota. , 2017, Environmental microbiology.

[142]  K. Dong,et al.  Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. , 2017, Journal of affective disorders.

[143]  T. Arumugam,et al.  HDAC Inhibitor Sodium Butyrate-Mediated Epigenetic Regulation Enhances Neuroprotective Function of Microglia During Ischemic Stroke , 2017, Molecular Neurobiology.

[144]  Yan Wang,et al.  Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids , 2016, PloS one.

[145]  John M Denu,et al.  Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues. , 2016, Molecular cell.

[146]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[147]  K. Fassbender,et al.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.

[148]  T. Dinan,et al.  Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals , 2016, Trends in Neurosciences.

[149]  T. Dinan,et al.  The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? , 2016, Neurochemistry International.

[150]  Hubert Preissl,et al.  Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. , 2016, Physiological reviews.

[151]  T. Schwartz,et al.  Opposite Regulation of Ghrelin and Glucagon-like Peptide-1 by Metabolite G-Protein-Coupled Receptors , 2016, Trends in Endocrinology & Metabolism.

[152]  K. Hase,et al.  Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis. , 2016, International immunopharmacology.

[153]  E. Elinav,et al.  Metabolites: messengers between the microbiota and the immune system , 2016, Genes & development.

[154]  K. Nishida,et al.  Probiotic Lactobacillus casei strain Shirota relieves stress‐associated symptoms by modulating the gut–brain interaction in human and animal models , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[155]  Young-Bum Kim,et al.  Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood , 2016, Molecular metabolism.

[156]  Masahiko Watanabe,et al.  Neural FFA3 activation inversely regulates anion secretion evoked by nicotinic ACh receptor activation in rat proximal colon , 2016, The Journal of physiology.

[157]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[158]  A. Fischer,et al.  Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis. , 2016, Cell reports.

[159]  W. Garrett,et al.  Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.

[160]  K. Petersen,et al.  Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome , 2016, Nature.

[161]  E. Chambers,et al.  Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods123 , 2016, The American journal of clinical nutrition.

[162]  Oluf Pedersen,et al.  Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials , 2016, Genome Medicine.

[163]  K. Rudi,et al.  Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? , 2016, BMC Gastroenterology.

[164]  L. Wojtczak,et al.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective , 2016, Journal of Lipid Research.

[165]  Renan Corrêa-Oliveira,et al.  Regulation of immune cell function by short-chain fatty acids , 2016, Clinical & translational immunology.

[166]  T. Yada,et al.  Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist , 2016, Journal of diabetes investigation.

[167]  A. Jaggi,et al.  An Integrative Review on Role and Mechanisms of Ghrelin in Stress, Anxiety and Depression. , 2016, Current drug targets.

[168]  F. Bergquist,et al.  GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality , 2016, Psychoneuroendocrinology.

[169]  E. Elliott,et al.  Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model , 2016, Neuropharmacology.

[170]  A. Margolles,et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..

[171]  Priscilla L. Yang.  Metabolomics and Lipidomics , 2016, Viral Pathogenesis.

[172]  Junjie Yu,et al.  Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis , 2016, Neuroscience Letters.

[173]  C. K. Yao,et al.  Review article: insights into colonic protein fermentation, its modulation and potential health implications , 2016, Alimentary pharmacology & therapeutics.

[174]  B. Shenderov,et al.  Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota , 2016, Microbial ecology in health and disease.

[175]  N. Sudo,et al.  Gut Dysbiosis in Patients with Anorexia Nervosa , 2015, PloS one.

[176]  P. Brigidi,et al.  The effect of short-chain fatty acids on human monocyte-derived dendritic cells , 2015, Scientific Reports.

[177]  J. Delcour,et al.  Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin , 2015, Nutrients.

[178]  R. Gold,et al.  Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. , 2015, Immunity.

[179]  Ellen E. Blaak,et al.  Short-chain fatty acids in control of body weight and insulin sensitivity , 2015, Nature Reviews Endocrinology.

[180]  J. Galanko,et al.  Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome , 2015, The American Journal of Gastroenterology.

[181]  B. Sánchez,et al.  Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria , 2015, Front. Microbiol..

[182]  Bing Ruan,et al.  Altered fecal microbiota composition in patients with major depressive disorder , 2015, Brain, Behavior, and Immunity.

[183]  Robert J. Moore,et al.  Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites , 2015, Nature Communications.

[184]  I. Amit,et al.  Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.

[185]  David S. Wishart,et al.  Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction , 2015, PloS one.

[186]  T. Schwartz,et al.  Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia , 2015, Neuroscience.

[187]  M. Priyadarshini,et al.  FFAR3 modulates insulin secretion and global gene expression in mouse islets , 2015, Islets.

[188]  S. Shultz,et al.  Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats , 2015, Behavioural Brain Research.

[189]  C. Borchers,et al.  An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. , 2015, Analytica chimica acta.

[190]  G. Frost,et al.  The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents , 2014, International Journal of Obesity.

[191]  C. Mantzoros,et al.  Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders. , 2015, Metabolism: clinical and experimental.

[192]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[193]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[194]  F. Barkhof,et al.  GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans , 2014, Diabetes.

[195]  Justine W. Debelius,et al.  Specialized metabolites from the microbiome in health and disease. , 2014, Cell metabolism.

[196]  J. Morgan,et al.  Upregulation of GPR109A in Parkinson’s Disease , 2014, PloS one.

[197]  H. Flint,et al.  ‘ Diet, gut microbiology and human health , 2015 .

[198]  T. Dinan,et al.  Microbiota and neurodevelopmental windows: implications for brain disorders. , 2014, Trends in molecular medicine.

[199]  W. D. de Vos,et al.  Differential Modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of Host Peripheral Lipid Metabolism and Histone Acetylation in Mouse Gut Organoids , 2014, mBio.

[200]  C. Mackay,et al.  Diet, metabolites, and "western-lifestyle" inflammatory diseases. , 2014, Immunity.

[201]  G. Tsujimoto,et al.  Regulation of Energy Homeostasis by GPR41 , 2014, Front. Endocrinol..

[202]  Jimmy D Bell,et al.  The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism , 2014, Nature Communications.

[203]  G. Gloor,et al.  Evidence for Greater Production of Colonic Short Chain Fatty Acids in Overweight than Lean Humans , 2014, International Journal of Obesity.

[204]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[205]  T. Junt,et al.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.

[206]  R. Medzhitov,et al.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition , 2014, Proceedings of the National Academy of Sciences.

[207]  H. Gerstein,et al.  The role of Homer1c in metabotropic glutamate receptor‐dependent long‐term potentiation , 2014, Hippocampus.

[208]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[209]  Rebecca Wall,et al.  Bacterial neuroactive compounds produced by psychobiotics. , 2014, Advances in experimental medicine and biology.

[210]  S. Ikeda,et al.  β-Hydroxybutyrate Modulates N-Type Calcium Channels in Rat Sympathetic Neurons by Acting as an Agonist for the G-Protein-Coupled Receptor FFA3 , 2013, The Journal of Neuroscience.

[211]  James E. Richards,et al.  The Gut Hormone Glucagon-like Peptide-1 Produced in Brain: Is This Physiologically Relevant? This Review Comes from a Themed Issue on Endocrine and Metabolic Diseases , 2022 .

[212]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[213]  T. Schwartz,et al.  Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. , 2013, Molecular metabolism.

[214]  G. Réus,et al.  Effects of sodium butyrate in animal models of mania and depression: implications as a new mood stabilizer. , 2013, Behavioural pharmacology.

[215]  M. Icaza-Chávez,et al.  Gut microbiota in health and disease , 2013 .

[216]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[217]  L. O’Brien,et al.  Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease , 2013, Neuroscience.

[218]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[219]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[220]  S. Zeisel,et al.  A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids , 2013, Metabolomics.

[221]  Jonathan R. Brestoff,et al.  Commensal bacteria at the interface of host metabolism and the immune system , 2013, Nature Immunology.

[222]  C. Philippe,et al.  Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent , 2013, BMC Biology.

[223]  H. Smidt,et al.  A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. , 2013, The Journal of nutrition.

[224]  G. Gloor,et al.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut , 2013, Microbiome.

[225]  James Versalovic,et al.  Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation , 2013, Therapeutic advances in gastroenterology.

[226]  U. Sundaram,et al.  Monocarboxylate 4 Mediated Butyrate Transport in a Rat Intestinal Epithelial Cell Line , 2013, Digestive Diseases and Sciences.

[227]  Amin R. Mazloom,et al.  Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages , 2012, Nature Immunology.

[228]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[229]  D. Macfabe,et al.  Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders , 2012, Microbial ecology in health and disease.

[230]  M. Blaser,et al.  Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.

[231]  Christian Panse,et al.  Identification of Combinatorial Patterns of Post-Translational Modifications on Individual Histones in the Mouse Brain , 2012, PloS one.

[232]  M. Angley,et al.  Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder , 2012, Digestive Diseases and Sciences.

[233]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[234]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[235]  S. Bloom,et al.  Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity , 2012, Gut and liver.

[236]  S. Finegold.  Desulfovibrio species are potentially important in regressive autism. , 2011, Medical hypotheses.

[237]  K. Kangawa,et al.  Plasma ghrelin concentration is decreased by short chain fatty acids in wethers. , 2011, Domestic animal endocrinology.

[238]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[239]  M. Noakes,et al.  Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. , 2011, The Journal of nutrition.

[240]  Andrew H. Miller,et al.  Immune system to brain signaling: neuropsychopharmacological implications. , 2011, Pharmacology & therapeutics.

[241]  James B. Adams,et al.  Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity , 2011, BMC gastroenterology.

[242]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[243]  D. Cain,et al.  Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder , 2011, Behavioural Brain Research.

[244]  Narbad Arjan,et al.  The study on the impact of glycated pea proteins on human intestinal bacteria. , 2011 .

[245]  G. Bertilsson,et al.  The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. , 2011, European journal of pharmacology.

[246]  E. Lam,et al.  Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells* , 2010, The Journal of Biological Chemistry.

[247]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[248]  Eunseog Youn,et al.  Pyrosequencing study of fecal microflora of autistic and control children. , 2010, Anaerobe.

[249]  N. Lambert,et al.  Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases , 2010, The Journal of Biological Chemistry.

[250]  B. Finlay,et al.  Gut microbiota in health and disease. , 2010, Physiological reviews.

[251]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[252]  David E. J. Jones,et al.  Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis , 2010, Hepatology.

[253]  D. Perez-Tilve,et al.  GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans. , 2010, Endocrinology.

[254]  P. de Coppet,et al.  Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. , 2010, Gastroenterology.

[255]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[256]  S. Fukudo,et al.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[257]  C. Dejong,et al.  Short chain fatty acids exchange across the gut and liver in humans measured at surgery. , 2009, Clinical nutrition.

[258]  Wayne W. Hancock,et al.  Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells , 2009, Nature Reviews Drug Discovery.

[259]  D. Naslain,et al.  Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. , 2009, The American journal of clinical nutrition.

[260]  T. Wolever,et al.  Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α , 2009, British Journal of Nutrition.

[261]  Justin R. Cross,et al.  ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009, Science.

[262]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[263]  D. Schrenk,et al.  Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. , 2008, The Journal of nutritional biochemistry.

[264]  S. Ito,et al.  Expression of peptide YY in human brain and pituitary tissues. , 2008, Nutrition.

[265]  D. Wishart,et al.  The human cerebrospinal fluid metabolome. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[266]  G. Cresci,et al.  Sodium-Coupled Transport of the Short Chain Fatty Acid Butyrate by SLC5A8 and Its Relevance to Colon Cancer , 2008, Journal of Gastrointestinal Surgery.

[267]  M. Usami,et al.  Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. , 2008, Nutrition research.

[268]  D. Cain,et al.  Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism , 2008, Neuropharmacology.

[269]  D. Jonkers,et al.  Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.

[270]  Kristian Daly,et al.  Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. , 2007, Gastroenterology.

[271]  E. Olson,et al.  Deacetylase inhibition promotes the generation and function of regulatory T cells , 2007, Nature Medicine.

[272]  H. Flint,et al.  Cultivable bacterial diversity from the human colon , 2007, Letters in applied microbiology.

[273]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[274]  J. Grider,et al.  The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[275]  T. Iwanaga,et al.  Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. , 2006, Biomedical research.

[276]  F. Kamp,et al.  How fatty acids of different chain length enter and leave cells by free diffusion. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[277]  H. Vidal,et al.  Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. , 2005, The American journal of clinical nutrition.

[278]  Manuel Desco,et al.  The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem , 2005, Journal of neurochemistry.

[279]  A. Walter,et al.  Monocarboxylic acid permeation through lipid bilayer membranes , 2005, The Journal of Membrane Biology.

[280]  V. Ganapathy,et al.  Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids* , 2004, Journal of Biological Chemistry.

[281]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids , 2004, British journal of pharmacology.

[282]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[283]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR 41 , 2004 .

[284]  D. Topping,et al.  Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. , 2003, The Journal of nutrition.

[285]  S. V. van Deventer,et al.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. , 2003, Gut.

[286]  W. Banks,et al.  Glucagon-like peptide-1 receptor is involved in learning and neuroprotection , 2003, Nature Medicine.

[287]  M. Fujimiya,et al.  Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[288]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[289]  G. Macfarlane,et al.  Regulation of short-chain fatty acid production , 2003, Proceedings of the Nutrition Society.

[290]  H. Flint,et al.  Acetate Utilization and Butyryl Coenzyme A (CoA):Acetate-CoA Transferase in Butyrate-Producing Bacteria from the Human Large Intestine , 2002, Applied and Environmental Microbiology.

[291]  B. Hinnebusch,et al.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. , 2002, The Journal of nutrition.

[292]  S. Shirazi-Beechey,et al.  The human monocarboxylate transporter, MCT1: genomic organization and promoter analysis. , 2002, Biochemical and biophysical research communications.

[293]  T. Sarkola,et al.  Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. , 2002, Alcoholism, clinical and experimental research.

[294]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[295]  F. Bornet,et al.  Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria , 2000, European Journal of Clinical Nutrition.

[296]  J. Sellin.  SCFAs: The Enigma of Weak Electrolyte Transport in the Colon. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[297]  Shree P. Singh.  Production and Utilization , 1999 .

[298]  Sellin,et al.  Review article: short chain fatty acids in health and disease , 1998, Alimentary pharmacology & therapeutics.

[299]  C. Edwards,et al.  Short Chain Fatty Acids , 1999 .

[300]  H. Takanaga,et al.  Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. , 1995, Biochemical and biophysical research communications.

[301]  P. Mortensen,et al.  Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. , 1994, Gastroenterology.

[302]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[303]  E. Pomare,et al.  Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. , 1992, Gut.

[304]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[305]  E. Shoubridge,et al.  1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient , 1991, NMR in biomedicine.

[306]  N. Mascolo,et al.  Mechanism of short-chain fatty acid uptake by apical membrane vesicles of rat distal colon. , 1991, Gastroenterology.

[307]  E. N. Bergman.  Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.

[308]  C. M. Wood,et al.  Treatment of diversion colitis with short-chain-fatty acid irrigation. , 1989, The New England journal of medicine.

[309]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[310]  T. Midtvedt,et al.  Short-chain fatty acids in germfree mice and rats. , 1986, The Journal of nutrition.

[311]  A. Bjørneklett,et al.  Short-chain fatty acids in the normal human feces. , 1984, Scandinavian journal of gastroenterology.

[312]  A. Sarnaik,et al.  Quantification of short-chain fatty acids in plasma. , 1982, Clinical chemistry.

[313]  C. Bachmann,et al.  Short chain fatty acids in plasma and brain: quantitative determination by gas chromatography. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[314]  G. Devroede,et al.  Functions of the large intestine. , 1979, International review of physiology.

[315]  W. James,et al.  Short chain fatty acid absorption by the human large intestine. , 1978, Gut.

[316]  V. Ingram,et al.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.

[317]  L. R. Hackler,et al.  Dietary fiber. , 1976, The Journal of nutrition.

[318]  F J Ballard,et al.  Production and utilization of acetate in mammals. , 1974, The Biochemical journal.

[319]  W H Oldendorf,et al.  Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. , 1973, The American journal of physiology.

[320]  E. Dunlop.  On anxiety and depression. , 1969, Psychosomatics.

[321]  T. Gallagher,et al.  Cholesterol synthesis from C14-acetate in man. , 1954, The Journal of clinical investigation.

[322]  M. Fink.  from in the Gut , 2022 .

[323]  T.,et al.  CHOLESTEROL SYNTHESIS FROM C 14-ACETATE IN MAN ' By LEON HELLMAN , 2022 .